AP2009004834A0 - Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases - Google Patents

Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases

Info

Publication number
AP2009004834A0
AP2009004834A0 AP2009004834A AP2009004834A AP2009004834A0 AP 2009004834 A0 AP2009004834 A0 AP 2009004834A0 AP 2009004834 A AP2009004834 A AP 2009004834A AP 2009004834 A AP2009004834 A AP 2009004834A AP 2009004834 A0 AP2009004834 A0 AP 2009004834A0
Authority
AP
ARIPO
Prior art keywords
ompounds
spirochete
immunomodulatory
compositions
management
Prior art date
Application number
AP2009004834A
Other languages
English (en)
Inventor
Jennifer Hensel
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of AP2009004834A0 publication Critical patent/AP2009004834A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2009004834A 2006-10-19 2007-10-19 Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases AP2009004834A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85284606P 2006-10-19 2006-10-19
PCT/US2007/022388 WO2008057196A2 (en) 2006-10-19 2007-10-19 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases

Publications (1)

Publication Number Publication Date
AP2009004834A0 true AP2009004834A0 (en) 2009-04-30

Family

ID=39364972

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004834A AP2009004834A0 (en) 2006-10-19 2007-10-19 Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases

Country Status (8)

Country Link
US (1) US20110184025A1 (de)
EP (1) EP2081561A2 (de)
JP (1) JP2010506937A (de)
CN (1) CN101557806A (de)
AP (1) AP2009004834A0 (de)
CA (1) CA2665778A1 (de)
MX (1) MX2009003912A (de)
WO (1) WO2008057196A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
SG10201501062SA (en) 2010-02-11 2015-04-29 Celgene Corp Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
WO2013036187A1 (en) * 2011-09-07 2013-03-14 Alpha Biotech Ab Determination of bacterial infections of the genus rickettsia and possibly borrelia, in patients exhibiting symptoms of disease and being blood donors
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection
CA2907908A1 (en) 2013-04-02 2014-10-09 Celgene Corporation Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers
EP2815749A1 (de) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Feste Form von 4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dion mit spezifischem Röntgenbeugungsspektrum
KR20230121863A (ko) 2020-12-17 2023-08-21 아이덱스 래보러토리즈, 인코포레이티드 로키산 홍반열 검출 및 치료

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182953B2 (en) * 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
NZ526683A (en) * 2000-11-30 2008-03-28 Childrens Medical Center Synthesis of 4-amino-thalidomide and its enantiomers that are suitable for inhibiting angiogenesis
NZ531294A (en) * 2001-08-06 2005-11-25 Childrens Medical Center Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
US7323479B2 (en) * 2002-05-17 2008-01-29 Celgene Corporation Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
EP2272513A1 (de) * 2002-05-17 2011-01-12 Celgene Corporation Pharmazeutische Zusammensetzungen zur Behandlung von Krebs
US7189740B2 (en) * 2002-10-15 2007-03-13 Celgene Corporation Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
ZA200503240B (en) * 2002-10-24 2007-11-28 Gelgene Corp Methods of using and compositions comprising immunodulatory compounds for treatment, modification and management of pain

Also Published As

Publication number Publication date
CN101557806A (zh) 2009-10-14
EP2081561A2 (de) 2009-07-29
JP2010506937A (ja) 2010-03-04
WO2008057196A2 (en) 2008-05-15
US20110184025A1 (en) 2011-07-28
WO2008057196A3 (en) 2008-07-24
CA2665778A1 (en) 2008-05-15
MX2009003912A (es) 2009-05-11

Similar Documents

Publication Publication Date Title
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
IL258730A (en) Preparations and methods for the treatment of microbial disorders
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
SI2182981T1 (sl) Postopki in sestavki za zdravljenje in diagnozo fibroze
ZA201001810B (en) Seed treatment compositions and methods
ZA201001811B (en) Seed treatment compositions and methods
GB201108374D0 (en) Compositions and methods for the treatment of altered synuclein function
PL2705826T3 (pl) Kompozycja fluorku i sposoby mineralizacji zębów
IL194387A0 (en) Methods and compositions for vaccination of poultry
ZA200704784B (en) Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200807398B (en) Compositions and methods for enhancing the antioxidant status of animals
ZA200907492B (en) Compositions for targeted imaging and therapy
IL198723A0 (en) Methods and compositions for therapeutic treatment
PL2101574T3 (pl) Związki i formulacje odpowiednie do wymiatania rodników
IL195412A0 (en) Methods and compositions using immunomodulatory compounds in combination therapy
IL208848A0 (en) Compositions for the treatment and prevention of infections of the oral cavity
EP2124968A4 (de) Zusammensetzungen und verfahren zur behandlung von muskelschwund
EP2076281A4 (de) Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren
HK1154911A (en) Methods and compositions for the treatment of huntington's disease
ZA200806668B (en) Antiseptic compositions and methods of using same
IL192614A0 (en) Antiseptic compositions and methods of using same
AU2007901739A0 (en) Methods and compositions for treatment of menorrhagia
AU2006903531A0 (en) Fluoride composition and methods for dental mineralization
HK1130684A (en) Methods and compositions for the treatment and prevention of infections